Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling.

Giordano TJ, Kuick R, Else T, Gauger PG, Vinco M, Bauersfeld J, Sanders D, Thomas DG, Doherty G, Hammer G.

Clin Cancer Res. 2009 Jan 15;15(2):668-76. doi: 10.1158/1078-0432.CCR-08-1067.

2.

Transcriptome analysis of adrenocortical cancers: from molecular classification to the identification of new treatments.

Ragazzon B, Assié G, Bertherat J.

Endocr Relat Cancer. 2011 Feb 23;18(2):R15-27. doi: 10.1530/ERC-10-0220. Print 2011 Apr. Review.

3.

The molecular basis of adrenocortical cancer.

Lehmann T, Wrzesinski T.

Cancer Genet. 2012 Apr;205(4):131-7. doi: 10.1016/j.cancergen.2012.02.009. Review.

PMID:
22559973
4.

Gene-expression profiling of adrenocortical carcinoma.

Suh I, Guerrero MA, Kebebew E.

Expert Rev Mol Diagn. 2009 May;9(4):343-51. Review.

PMID:
19441174
5.

The pathophysiology, diagnosis and prognosis of adrenocortical tumors revisited by transcriptome analyses.

Assié G, Guillaud-Bataille M, Ragazzon B, Bertagna X, Bertherat J, Clauser E.

Trends Endocrinol Metab. 2010 May;21(5):325-34. doi: 10.1016/j.tem.2009.12.009. Epub 2010 Jan 25. Review.

PMID:
20097573
6.

ENDOCRINE TUMOURS: The genomics of adrenocortical tumors.

Faillot S, Assie G.

Eur J Endocrinol. 2016 Jun;174(6):R249-65. doi: 10.1530/EJE-15-1118. Epub 2016 Jan 6. Review.

7.

Pathogenesis of adrenocortical cancer.

Bertherat J, Bertagna X.

Best Pract Res Clin Endocrinol Metab. 2009 Apr;23(2):261-71. doi: 10.1016/j.beem.2008.10.006. Review.

PMID:
19500768
8.

5th International ACC Symposium: Classification of Adrenocortical Cancers from Pathology to Integrated Genomics: Real Advances or Lost in Translation?

de Krijger RE, Bertherat J.

Horm Cancer. 2016 Feb;7(1):3-8. doi: 10.1007/s12672-015-0242-1. Epub 2015 Dec 16. Review.

PMID:
26676358
9.

Genomic and expression profiling of adrenocortical carcinoma: application to diagnosis, prognosis and treatment.

Bussey KJ, Demeure MJ.

Future Oncol. 2009 Jun;5(5):641-55. doi: 10.2217/fon.09.45. Review.

PMID:
19519204
10.

Adrenocortical growth and cancer.

Lefèvre L, Bertherat J, Ragazzon B.

Compr Physiol. 2015 Jan;5(1):293-326. doi: 10.1002/cphy.c140010. Review.

PMID:
25589272
11.

Future directions in the diagnosis and medical treatment of adrenocortical carcinoma.

Creemers SG, Hofland LJ, Korpershoek E, Franssen GJ, van Kemenade FJ, de Herder WW, Feelders RA.

Endocr Relat Cancer. 2016 Jan;23(1):R43-69. doi: 10.1530/ERC-15-0452. Epub 2015 Oct 16. Review.

12.

Molecular basis of adrenocortical carcinomas.

Soon PS, Sidhu SB.

Minerva Endocrinol. 2009 Jun;34(2):137-47. Review.

PMID:
19471238
13.

Molecular markers of adrenocortical tumors.

Jain M, Rechache N, Kebebew E.

J Surg Oncol. 2012 Oct 1;106(5):549-56. doi: 10.1002/jso.23119. Epub 2012 Apr 13. Review.

PMID:
22504887
14.

Molecular markers and targeted therapies for adrenocortical carcinoma.

Xu Y, Qi Y, Zhu Y, Ning G, Huang Y.

Clin Endocrinol (Oxf). 2014 Feb;80(2):159-68. doi: 10.1111/cen.12358. Epub 2013 Dec 5. Review.

PMID:
24304415
15.

Genetics and epigenetics of adrenocortical tumors.

Lerario AM, Moraitis A, Hammer GD.

Mol Cell Endocrinol. 2014 Apr 5;386(1-2):67-84. doi: 10.1016/j.mce.2013.10.028. Epub 2013 Nov 9. Review.

16.

MicroRNA era: the importance for diagnosis and prognosis of adrenocortical tumors.

Bezerra JE, Latronico AC.

Biomed Res Int. 2014;2014:381917. doi: 10.1155/2014/381917. Epub 2014 Jun 23. Review.

17.

The 'omics' of adrenocortical tumours for personalized medicine.

Assié G, Jouinot A, Bertherat J.

Nat Rev Endocrinol. 2014 Apr;10(4):215-28. doi: 10.1038/nrendo.2013.272. Epub 2014 Feb 4. Review.

PMID:
24492180

Supplemental Content

Support Center